Vyvgart
Chemical Name | efgartigimod alfa-fcab |
Dosage Form | Injection (intravenous; (20 mg/mL) |
Drug Class | Receptor antagonists |
System | Musculoskeletal |
Company | Argenx |
Approval Year | 2021 |
Indication
- For the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive